96. Meet-the-Professor
Session: Meet-the-Professor Session: Antimicrobial Dosing in Special Populations
Friday, October 21, 2011: 8:00 AM
Room: 204AB

Ayman Noreddin, PhD, University of Minnesota, Duluth, MN

Ayman M. Noreddin
*American College of Clinical Pharmacy Research Fellowship (Infectious Diseases).
*Pharmacokinetic/Pharmacodynamic Research Fellowship (Infectious Diseases),
Faculty of Medicine, University of Manitoba
*Visiting Scholar, Department of Medicine, Stanford University
*Ph.D. [Pharmaceutical Sciences (Clinical Pharmacy)], University of the Pacific.
*MSc. [Pharmaceutical Sciences (biochemistry)], Cairo University.
*B.Sc. Pharmaceutical Sciences, Cairo University.
Recent Professional Experience:
-2004 Associate Professor, Internal Medicine (Clinical Pharmacokinetics)
Department of Pharmacy Practice and Pharmaceutical Sciences
College of Pharmacy (Duluth), University of Minnesota
-2004 Assistant Professor, Clinical Pharmacology
Department of Medical Microbiology/Infectious Diseases
Faculty of Medicine, University of Manitoba, Winnipeg, Canada
-2001- 2004 Director, Clinical Pharmacology Research, Manitoba Antibiotic Research Laboratory,
Department of Medical Microbiology, Faculty of Medicine, University of Manitoba.

Recent Awards and Research Grants:
- American College of Clinical Pharmacy/Aventis Pharmacotherapy Research Fellowship (Infectious Diseases), 2002-2004.
- Principal Investigator: “Target Attainment Analysis for Gatifloxacin 400 Daily in Immunocompetent Elderly and Immunocompromised Patients Hospitalized with Community Acquired Pneumonia”, Bristol Meyers Squibb, 20002-2003 ($22,000)
- Co-investigator: “Pharmacokinetic/Pharmacodynamic modeling of various Nitrofurantoin formulations versus selected urinary tract isolates, “ Procter and Gamble, 2000-2002 ($160.000)

<< Previous Presentation | Next Presentation

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.